Mast cells infiltration and decreased E-cadherin expression in ketamine-induced cystitis

Toxicology Reports

Volumn 2, Issue , 2015, Pages 205-209

  Li, Mengqiang ^a   Yang, Kang ^a   Wang, Xiujian ^a   Xu, Xiaodong ^a   Zhu, Ling ^a   Wang, Huili ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Bladder; Cystitis; E cadherin; Ketamine; Mice

Indexed keywords

KETAMINE; TRYPTASE; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYSTITIS; ELECTRON MICROSCOPY; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAST CELL; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; WEIGHT FLUCTUATION;

EID: 84925500337     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2014.12.003     Document Type: Article

References (16)

1. Hills C.E., Jin T., Siamantouras E., Liu I.K., Jefferson K.P., Squires P.E. 'Special k' and a loss of cell-to-cell adhesion in proximal tubule-derived epithelial cells: modulation of the adherens junction complex by ketamine. PLoS ONE 2013, 8:e71819.
2. Tsai T.H., Cha T.L., Lin C.M., et al. Ketamine-associated bladder dysfunction. Int. J. Urol. 2009, 16:826-829.
3. Colebunders B., Van Erps P. Cystitis due to the use of ketamine as a recreational drug: a case report. J. Med. Case Rep. 2008, 2:219.
4. Chu P.S., Kwok S.C., Lam K.M., et al. 'Street ketamine'-associated bladder dysfunction: a report of ten cases. Hong Kong Med. J. 2007, 13:311-313.
5. Reinhardt S., Fode M. Bladder pain and urinary tract symptoms as a consequence of ketamine abuse. Ugeskr. Laeger 2014, 176:240-242.
6. Castroman P.J., Ketamine Ness T.J. an N-methyl-d-aspartate receptor antagonist, inhibits the reflex responses to distension of the rat urinary bladder. Anesthesiology 2002, 96:1401-1409.
7. Castroman P.J., Ketamine Ness T.J. an N-methyl-d-aspartate receptor antagonist, inhibits the spinal neuronal responses to distension of the rat urinary bladder. Anesthesiology 2002, 96:1410-1419.
8. Gonzalez-Cadavid N.F., Ryndin I., Vernet D., Magee T.R., Rajfer J. Presence of NMDA receptor subunits in the male lower urogenital tract. J. Androl. 2000, 21:566-578.
9. Sun L., Lam W.P., Wong Y.W., et al. Permanent deficits in brain functions caused by long-term ketamine treatment in mice. Hum. Exp. Toxicol. 2011, 30:1287-1296.
10. Rudick C.N., Bryce P.J., Guichelaar L.A., Berry R.E., Klumpp D.J. Mast cell-derived histamine mediates cystitis pain. PLoS ONE 2008, 3:e2096.
11. Vasconcelos-Nobrega C., Costa C., Vala H., et al. E-cadherin and beta-catenin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in mice. Urol. Int. 2013, 91:462-466.
12. Theoharides T.C., Kempuraj D., Sant G.R. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology 2001, 57:47-55.
13. Theoharides T.C., Sant G.R. Bladder mast cell activation in interstitial cystitis. Semin. Urol. 1991, 9:74-87.
14. Aydin H., Ercan F., Cetinel S., San T. Morphological examination of the effects of defibrotide on experimentally induced bladder injury and its relation to interstitial cystitis. Urol. Res. 2001, 29:263-271.
15. Liu H.T., Shie J.H., Chen S.H., Wang Y.S., Kuo H.C. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome. Urology 2012, 80(225):213-228.
16. Lee C.L., Jiang Y.H., Kuo H.C. Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls. BJU Int. 2013, 112:1156-1162.